Results
|
28061.
|
Treatment of advanced Hodgkin's disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin's Lymphoma Study Group HD6 trial. [electronic resource] by
- Sieber, M
- Tesch, H
- Pfistner, B
- Rueffer, U
- Paulus, U
- Munker, R
- Hermann, R
- Doelken, G
- Koch, P
- Oertel, J
- Roller, S
- Worst, P
- Bischof, H
- Glunz, A
- Greil, R
- von Kalle, K
- Schalk, K P
- Hasenclever, D
- Brosteanu, O
- Duehmke, E
- Georgii, A
- Engert, A
- Loeffler, M
- Diehl, V
- Mueller, R P
- Willich, N
- Fischer, R
- Hansmann, M L
- Stein, H
- Schober, T
- Koch, B
Producer: 20040601
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 15
Availability: No items available.
|
|
28062.
|
|
|
28063.
|
|
|
28064.
|
|
|
28065.
|
Synthesis, biological activity, QSAR and QSPR study of 2-aminobenzimidazole derivatives as potent H3-antagonists. [electronic resource] by
- Mor, Marco
- Bordi, Fabrizio
- Silva, Claudia
- Rivara, Silvia
- Zuliani, Valentina
- Vacondio, Federica
- Rivara, Mirko
- Barocelli, Elisabetta
- Bertoni, Simona
- Ballabeni, Vigilio
- Magnanini, Francesca
- Impicciatore, Mariannina
- Plazzi, Pier Vincenzo
Producer: 20040910
In:
Bioorganic & medicinal chemistry vol. 12
Availability: No items available.
|
|
28066.
|
|
|
28067.
|
|
|
28068.
|
|
|
28069.
|
|
|
28070.
|
|
|
28071.
|
|
|
28072.
|
|
|
28073.
|
|
|
28074.
|
|
|
28075.
|
|
|
28076.
|
|
|
28077.
|
|
|
28078.
|
|
|
28079.
|
BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model. [electronic resource] by
- Kurozumi, Kazuhiko
- Nakamura, Kiminori
- Tamiya, Takashi
- Kawano, Yutaka
- Kobune, Masayoshi
- Hirai, Sachie
- Uchida, Hiroaki
- Sasaki, Katsunori
- Ito, Yoshinori
- Kato, Kazunori
- Honmou, Osamu
- Houkin, Kiyohiro
- Date, Isao
- Hamada, Hirofumi
Producer: 20040917
In:
Molecular therapy : the journal of the American Society of Gene Therapy vol. 9
Availability: No items available.
|
|
28080.
|
AAV2 vector harboring a liver-restricted promoter facilitates sustained expression of therapeutic levels of alpha-galactosidase A and the induction of immune tolerance in Fabry mice. [electronic resource] by
- Ziegler, Robin J
- Lonning, Scott M
- Armentano, Donna
- Li, Chester
- Souza, David W
- Cherry, Maribeth
- Ford, Christine
- Barbon, Christine M
- Desnick, Robert J
- Gao, Guangping
- Wilson, James M
- Peluso, Richard
- Godwin, Simon
- Carter, Barrie J
- Gregory, Richard J
- Wadsworth, Samuel C
- Cheng, Seng H
Producer: 20040917
In:
Molecular therapy : the journal of the American Society of Gene Therapy vol. 9
Availability: No items available.
|